High prevalence of methotrexate use in patients with Epstein-Barr virus-positive mucocutaneous ulcer may cause confounding bias

Mod Pathol. 2021 Nov;34(11):2084. doi: 10.1038/s41379-021-00798-7. Epub 2021 Mar 23.

Authors

Maximiliano Ramia de Cap¹, Phillip D Michaels²

Affiliations

¹ Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA. mramia@bidmc.harvard.edu.
² Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.

PMID: 33758325
DOI: 10.1038/s41379-021-00798-7

No abstract available

Publication types

Letter

MeSH terms

Arthritis, Rheumatoid / drug therapy*
Epstein-Barr Virus Infections / diagnosis*
Epstein-Barr Virus Infections / etiology
Epstein-Barr Virus Infections / metabolism
Humans
Immunosuppressive Agents / adverse effects*
Lymphoma, Large B-Cell, Diffuse / diagnosis*
Lymphoma, Large B-Cell, Diffuse / metabolism
Methotrexate / adverse effects*
Oral Ulcer / chemically induced
Oral Ulcer / diagnosis*
Oral Ulcer / virology
Prevalence
Receptors, Interleukin-2 / metabolism

Substances

Immunosuppressive Agents
Receptors, Interleukin-2
Methotrexate